System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Clément Prati is an expert in Rheumatology at Centre Hospitalier Universitaire de Besançon (France). As of September 2026, ScienceLeadR ranks Clément Prati in the top 1% of experts worldwide for Spondylarthritis and Arthritis. Clément Prati has authored 469 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 1,306 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Clément Prati Centre Hospitalier Universitaire de Besançon France
1 306 ScienceLeadR Reputation 1306

Unlock

Register Login
Network Map

Rheumatology

Subspecialties: Pharmacy - Hematology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Besançon

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 469

Citations

Citations: 4 102 1st author: 38 Last author: 121 Unique author: 0

Main journals

Joint Bone Spine 125
Revue du Rhumatisme 77
Ann Rheum Dis 71
Revue du rhumatisme 63
J Rheumatol 14

Best Journals

Lancet Rheumatol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: results from the MAJIK-SFR registry.
PMID 42476357 — registries, joint diseases, risk assessment, arthritis, arthritis, rheumatoid, janus kinase inhibitors		Joint Bone Spine20260
Spondyloarthritis and inflammatory bowel disease: towards a more severe and refractory disease phenotype.
PMID 42370112 — phenotype, inflammatory bowel diseases, diagnosis, therapeutics, psoriasis, smoking, uveitis		EULAR Rheumatol Open20261
Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?
PMID 42176069 — rheumatologists, axial spondyloarthritis		Clin Rheumatol20260
Late-onset psoriatic arthritis: a separate entity.
PMID 42031138 — arthritis, psoriatic, comorbidity, arthritis, therapeutics		Joint Bone Spine20260
Bacterial translocation and intestinal permeability in early axial spondyloarthritis association with 5-year outcomes: insights from the DESIR cohort.
PMID 42018755 — sacroiliitis, rheumatic diseases, bacterial translocation, prognosis, axial spondyloarthritis		Rheumatology (Oxford)20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 3
Phase 3 2

By status:

Recruiting 3
Active not recruiting 1
Completed 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Justification AnD evaluation in pOlymyalgia RhEumatica of BARIcitinib versus placebo (JADORE BARI study)
2024-518385-26-01 — therapeutics, polymyalgia rheumatica		Phase 3Recruiting2025
Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica
NCT07279688 — glucocorticoids, comorbidity, safety, prednisone, adrenal cortex hormones, interleukin-6, tablets, physicians, therapeutics, janus kinase inhibitors, polymyalgia rheumatica, steroids		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS